| 陈冰清,王欣怡,叶桦.我国各省建立重点药品监控制度的比较[J].中国药事,2018,32(10):1314-1321 |
| 我国各省建立重点药品监控制度的比较 |
| A Comparison of Key Drug Monitoring Systems Established by Provinces in China |
| 投稿时间：2018-05-05 |
| DOI：10.16153/j.1002-7777.2018.10.002 |
| 中文关键词: 重点药品监控 合理用药 辅助用药 处方点评 |
| 英文关键词: key drug monitoring rational drug use adjuvant drugs prescription comment |
| 基金项目: |
|
| 摘要点击次数: 1084 |
| 全文下载次数: 657 |
| 中文摘要: |
| 目的：为进一步完善重点药品监控制度提出参考建议。方法：检索各省市卫计委网站，收集全国各省、自治区、直辖市（港澳台地区除外）有关重点药品监控的文件，进行比较分析。结果：自2015年以来，各省级人民政府或卫生计生部门相继出台了有关“重点药品监控”的规范性文件，文件内容包含重点药品监控的责任部门及其分工，监控目录的制定，以及处方点评、预警通报制度、医师的能力培训、奖惩制度等措施。结论：重点药品监控制度应当以合理用药为核心，确定一个公认的重点监控药品的定义和范围，并逐步完善重点监控药品目录，加强处方点评；药品生产企业应当积极开展这些药品的上市后评价，发挥市场主导作用切断幕后利益推手。 |
| 英文摘要: |
| Objective: To provide suggestions for further improvement of key drug monitoring systems. Methods: The websites of the provincial and municipal health planning committees were searched, and the documents related to the monitoring of key drugs in all provinces, autonomous regions, and municipalities directly under the Central Government (excluding Hong Kong, Macao and Taiwan regions) were collected for comparative analysis. Results: The provincial governments of health and family planning departments have formulated normative documents on "key drug monitoring" in succession since 2015, which include the responsible department of key drug monitoring and its division of labor, the development of monitoring catalogue, as well as prescription comment, precautionary notification system, physicians' training, reward and punishment system, etc.. Conclusion: The key drug monitoring system should take rational drug use as the core, determine the definition and scope of a recognized key monitoring drug, gradually improve the list of key monitoring drugs and strengthen prescription comment. Drug manufacturers should actively carry out post-market evaluation of these drugs and play a leading role in the market in cutting off the behind-the-scenes interests. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|